Retinitis Pigmentosa Clinical Trials
Retinitis Pigmentosa is a group of inherited disease that usually begins with night blindness, followed by progressive loss of peripheral vision. In excess of a period of years this outcome in “tunnel vision,” and may lead to overall blindness. It causes the progressive deterioration of specialized, light-absorbing cells in the retina, the paper thin tissue that lines the back of the eye like film in a camera. The greater parts of people with Retinitis Pigmentosa are legally blind by the age of 40, with a central visual field of less than 20 degrees in diameter.
The majority adults person with blinding Retinitis Pigmentosa should take an on a daily basis 15,000 IU vitamin A palmitate supplement and avoid high dose vitamin E to help make longer their vision. This suggestion is the first from a well-designed clinical trial indicating that individual can be treated for Retinitis Pigmentosa. This Best Treatment for Retinitis Pigmentosa can be a benefit, a very correct one, for people who have Retinitis Pigmentosa. Although not a cure, it will get better quality of life, potentially adding many years of useful vision. The discovery that vitamin E is of no utilize, and in actual fact potentially harmful, is not only imperative on its own, but further justifies this extensive study.
The investigators stressed that adults considering vitamin A palmitate supplementation must first discuss with with their medical doctor. Fasting blood levels of vitamin A should be measured and liver function tests administered before starting Treatment of Retinitis Pigmentosa. People with certain pre-existing medical conditions may not be qualified for this treatment.